Clinical Trial Update: A Study to Evaluate Safety and Efficacy of Telotristat Etiprate (LX1606) in Participants With Acute, Mild to Moderate Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of telotristat etiprate (LX1606) in acute, mild to moderate ulcerative colitis completed with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Telotristat Etiprate (telotristat etiprate)

Snippet

Sponsor: Lexicon Pharmaceuticals | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED | Results posted: 2015-03-11